Colchicine for Secondary Cardiovascular Prevention in Coronary Disease
- PMID: 33196312
- DOI: 10.1161/CIRCULATIONAHA.120.051240
Colchicine for Secondary Cardiovascular Prevention in Coronary Disease
Keywords: Editorials; acute coronary syndrome; colchicines; coronary artery disease; inflammation; myocardial infarction.
Comment on
-
Colchicine in Patients With Acute Coronary Syndrome: The Australian COPS Randomized Clinical Trial.Circulation. 2020 Nov 17;142(20):1890-1900. doi: 10.1161/CIRCULATIONAHA.120.050771. Epub 2020 Aug 29. Circulation. 2020. PMID: 32862667 Clinical Trial.
-
Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease: A LoDoCo2 Proteomic Substudy.Circulation. 2020 Nov 17;142(20):1996-1998. doi: 10.1161/CIRCULATIONAHA.120.050560. Epub 2020 Aug 31. Circulation. 2020. PMID: 32864998 Clinical Trial. No abstract available.
Similar articles
-
Colchicine in Stable Coronary Artery Disease.Clin Ther. 2019 Jan;41(1):30-40. doi: 10.1016/j.clinthera.2018.09.011. Epub 2018 Nov 2. Clin Ther. 2019. PMID: 30396516 Review.
-
Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: a pooled analysis underling possible safety concerns.Eur Heart J Cardiovasc Pharmacother. 2021 May 23;7(3):e18-e19. doi: 10.1093/ehjcvp/pvaa137. Eur Heart J Cardiovasc Pharmacother. 2021. PMID: 33270128 No abstract available.
-
Is there a role for colchicine in secondary prevention of coronary artery disease?Eur J Prev Cardiol. 2022 Feb 3;28(17):1914-1915. doi: 10.1093/eurjpc/zwab064. Eur J Prev Cardiol. 2022. PMID: 34219144 No abstract available.
-
Response-letter to the editor: colchicine and risk of non-cardiovascular death in patients with coronary artery disease: a pooled analysis underlying possible safety concerns.Eur Heart J Cardiovasc Pharmacother. 2021 Jul 23;7(4):e72-e73. doi: 10.1093/ehjcvp/pvab024. Eur Heart J Cardiovasc Pharmacother. 2021. PMID: 33725116 No abstract available.
-
Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials.Eur Heart J. 2021 Jul 21;42(28):2765-2775. doi: 10.1093/eurheartj/ehab115. Eur Heart J. 2021. PMID: 33769515
Cited by
-
Study on the mechanism of action of colchicine in the treatment of coronary artery disease based on network pharmacology and molecular docking technology.Front Pharmacol. 2023 Jun 19;14:1147360. doi: 10.3389/fphar.2023.1147360. eCollection 2023. Front Pharmacol. 2023. PMID: 37405052 Free PMC article.
-
Anti-Inflammatory Therapy for Atherosclerosis: Focusing on Cytokines.Int J Mol Sci. 2021 Jun 30;22(13):7061. doi: 10.3390/ijms22137061. Int J Mol Sci. 2021. PMID: 34209109 Free PMC article. Review.
-
Association of Pericardiac Adipose Tissue With Coronary Artery Disease.Front Endocrinol (Lausanne). 2021 Sep 6;12:724859. doi: 10.3389/fendo.2021.724859. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34552562 Free PMC article.
-
Modulating inflammation to reduce atherosclerotic cardiovascular events: should colchicine be part of the therapeutic regimen?Ther Adv Cardiovasc Dis. 2021 Jan-Dec;15:17539447211042714. doi: 10.1177/17539447211042714. Ther Adv Cardiovasc Dis. 2021. PMID: 34533404 Free PMC article. No abstract available.
-
A Meta-Analysis Evaluating the Colchicine Therapy in Patients With Coronary Artery Disease.Front Cardiovasc Med. 2021 Dec 9;8:740896. doi: 10.3389/fcvm.2021.740896. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34957237 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical